A detailed history of Salem Investment Counselors Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Salem Investment Counselors Inc holds 1,777 shares of CRSP stock, worth $82,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,777
Previous 1,775 0.11%
Holding current value
$82,257
Previous $95,000 12.63%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$44.62 - $62.75 $89 - $125
2 Added 0.11%
1,777 $83,000
Q1 2024

Apr 11, 2024

SELL
$60.67 - $89.12 $1,820 - $2,673
-30 Reduced 1.66%
1,775 $120,000
Q3 2023

Oct 04, 2023

BUY
$45.39 - $59.0 $80,567 - $104,725
1,775 Added 5916.67%
1,805 $81,000
Q2 2023

Jul 19, 2023

BUY
$43.47 - $67.77 $1,304 - $2,033
30 New
30 $1,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.